Inventor · disambiguated record
Aaron Cooper
Also filed as: COOPER AARON · COOPER AARON R · COOPER AARON ROSS
4 granted patents·16 pending applications·7 citations·filing 2013–2025
68Inventor score
Top patents by PatentIndex Score
20 records- 0190US11332744B1Safe harbor lociARSENAL BIOSCIENCES INC·Filed 2021·Granted May 17, 2022·4 cites·30 claims
- 0287US12037407B2Immune cells having co-expressed shRNAS and logic gate systemsARSENAL BIOSCIENCES INC·Filed 2023·Granted Jul 16, 2024·2 cites·71 claims
- 0385US11761004B2Safe harbor lociARSENAL BIOSCIENCES INC·Filed 2022·Granted Sep 19, 2023·1 cites·32 claims
- 0472US2024309106A1Immune cells having co-expressed shrnas and logic gate systemsARSENAL BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0572US2023416747A1Safe harbor lociARSENAL BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0665US2025049854A1Cells comprising a suppressor of gene expression and/or a syntheticpathway activator and/or an inducible payloadARSENAL BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 0763US2025084492A1Pathogen diagnostic testOCTANT INC·Filed 2024·Application pending·0 cites
- 0862US2023340409A1Engineered immune cells with priming receptorsARSENAL BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0961US2024240164A1Non-viral homology mediated end joiningARSENAL BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1060US2025250350A1Immune cells having co-expressed shrnas and logic gate systemsArsenal Biosciences·Filed 2025·Application pending·0 cites
- 1155US2024082427A1Method of designing highly regulated lentiviral vectors possesing strict endogenous regulationUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1252US2022235380A1Immune cells having co-expressed shrnas and logic gate systemsARSENAL BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1351US12129523B2Pathogen diagnostic testOCTANT INC·Filed 2021·Granted Oct 29, 2024·0 cites·16 claims
- 1450US2022136007A1Optimized lentiviral vector compromising minimal enhancer elements for stem cell gene therapy of hemoglobinopathiesUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 1549US2022177897A1Transcriptional relay systemOCTANT INC·Filed 2021·Application pending·0 cites
- 1649US2023365997A1Compositions and methods of genomic modification of cells and uses thereofARSENAL BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1746US2015224209A1Lentiviral vector for stem cell gene therapy of sickle cell diseaseKOHN DONALD B·Filed 2013·Application pending·0 cites
- 1846US2017157270A1Lentiviral vector for stem cell gene therapy of sickle cell diseaseUNIV CALIFORNIA·Filed 2016·Application pending·0 cites
- 1941US2025215438A1Immune cells having co-expressed tgfbr shrnasARSENAL BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 2033US2018185415A1Retroviral vectors containing a reverse orientation human ubiquitin c promoterUNIV CALIFORNIA·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Aaron Cooper files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →